Non-surgical procedures encompass a range of medical treatments that do not require invasive incisions, finding a significant application in cosmetic dermatology. They offer minimally invasive alternatives to traditional surgeries, and they are famous for aesthetic enhancements. Common procedures include injectables such as Botox and dermal fillers for wrinkle reduction, alongside laser therapy for skin rejuvenation and non-invasive body contouring such as Cool Sculpting. The market for these procedures is expanding as advancements in technology and techniques provide safer, more effective options for patients seeking to enhance their appearance with minimal risk and downtime.
Global Non-Surgical Procedures Market size was valued at USD 61,200.00 million in 2022 and is projected to reach USD 192,485.44 million by 2030, with a CAGR of 15.4% during the forecast period of 2023-2030.
To know more, visit https://www.databridgemarketresearch.com/reports/global-non-surgical-procedures-market
Below are the Top Non-Surgical Procedures Companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
Allergan
|
A global pharmaceutical company, Allergan is renowned for its extensive portfolio of aesthetic products, including Botox, Juvederm, and CoolSculpting, which are widely used in non-surgical procedures. It dominates the market with innovative treatments for facial aesthetics and body contouring, catering to diverse patient needs worldwide.
|
|
North America, Europe, Asia-Pacific, and Middle East and Africa
|
In October 2020, Allergan (A Subsidiary of AbbVie Inc.) announced that it has agreed with Luminera, which is a privately held aesthetics company with a portfolio and pipeline of dermal filler products. It is estimated that this acquisition will strengthen its footprints in the Israeli market.
|
|
2.
|
Galderma
|
Galderma specializes in dermatology and aesthetic medicine, offering a range of non-surgical solutions for skin health and beauty. Their product lineup includes fillers such as Restylane and Dysport for wrinkle reduction, as well as skincare products tailored to complement aesthetic treatments, solidifying their position in the non-surgical procedures market.
|
|
North America, Europe, Asia-Pacific, and others
|
In November 2020, Galderma launched Dysport in China for the treatment of glabellar lines. It is predicted that this product launch will enhance business growth and strengthen the company's footprint in the Chinese market.
|
|
3.
|
Merz Pharma
|
Merz Pharma focuses on developing and marketing aesthetic and neurotoxin products for both medical and cosmetic purposes. With offerings such as Xeomin and Radiesse, Merz Pharma plays a significant role in non-surgical procedures, providing clinicians and patients with reliable options for facial rejuvenation and enhancement.
|
|
North America, South America, Asia-Pacific, Europe, and Middle East
|
In June 2020, Merz Pharma and Teijin Pharma Limited jointly announced the approval by Japan’s Ministry of Health, Labor and Welfare (MHLW) to market Xeomin (incobotulinumtoxinA). This approval is anticipated to accelerate the company's revenue growth in the coming years.
|
|
4.
|
Johnson & Johnson Services, Inc.
|
While Johnson & Johnson is a diversified healthcare conglomerate, its subsidiary, Janssen Pharmaceuticals, offers aesthetic products such as Juvederm through its aesthetics division. These offerings contribute to the non-surgical procedures market, enhancing the company's presence in the field of cosmetic dermatology and facial aesthetics.
|
|
North America, Europe, Asia-Pacific, and others
|
In September 2020, Johnson & Johnson Services, Inc. announced the launch of the Skincare of the Future QuickFire Challenge in collaboration with Zhejiang Tmall Technology Co., Ltd. This strategy is calling for new innovative products, services, and technology innovations to help consumers tackle some of the world's toughest skincare challenges.
|
|
5.
|
Medytox
|
Medytox is a South Korean biopharmaceutical company known for its botulinum toxin product, Meditoxin. As a significant player in the global market for neurotoxin-based treatments, particularly in Asia, Medytox influences the landscape of non-surgical procedures by providing effective solutions for facial wrinkles and muscle spasms.
|
|
Europe, Asia-Pacific, North America, and others
|
In January 2020, Medytox received approval for liquid-type BTX ‘INNOTOX 100 unit’ in the domestic market from the Ministry of Food and Drug Safety (MFDS). It is predicted that this product approval will enhance the company's revenue growth in the coming years.
|
Conclusion
In the non-surgical procedures market, companies such as Allergan, Galderma, Merz Pharma, Johnson & Johnson Services, Inc., and Medytox stand as key players, each contributing unique innovations to meet the growing demand for minimally invasive aesthetic solutions. With a diverse range of products spanning from botulinum toxins to dermal fillers and skincare, these companies shape the landscape of cosmetic dermatology worldwide. As the market continues to evolve, these companies remain at the forefront, driving advancements that redefine beauty standards and empower individuals to look and feel their best without undergoing invasive procedures.
